We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Wants More Information on GSK’s Cervarix
FDA Wants More Information on GSK’s Cervarix
December 21, 2007
The FDA sent a complete response letter to GlaxoSmithKline (GSK) requesting more information before approving the company’s cervical cancer vaccine Cervarix.